# FDA 483 - Airgas USA, LLC - March 02, 2021

Source: https://www.keypedia.com/records/483/airgas-usa-llc/18915352-58bc-4b2b-a2e3-03c0034066bd

> FDA 483 for Airgas USA, LLC on March 02, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Airgas USA, LLC
- Inspection Date: 2021-03-02
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Airgas USA, LLC in Fort Collins, CO, a medical gas transfiller, identified four significant deficiencies. These included the distribution of medical oxygen without proper quality control review, inadequate employee training on cGMP procedures, and a lack of continuing GMP training documentation. Additionally, the firm failed to provide documentation for the routine calibration of scales used in the production of liquid medical oxygen and nitrogen.

## Related Officers

- [Pharmaceutical Program Expert](https://www.keypedia.com/people/zachary-l-stamm/b729fab9-4d31-4c70-b5b3-e8b6207769c6)

Company: https://www.keypedia.com/companies/airgas-usa-llc/77906ce6-4c76-4e6f-a6f9-d94dc56e6a7e

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face